Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Individual susceptibility to hexavalent chromium of workers of shoe, hide, and leather industries. Immunological pattern of HLA-B8, DR3-positive subjects.

Mignini F, Streccioni V, Baldo M, Vitali M, Indraccolo U, Bernacchia G, Cocchioni M.

Prev Med. 2004 Oct;39(4):767-75.

PMID:
15351544
2.

Immunological pattern alteration in shoe, hide, and leather industry workers exposed to hexavalent chromium.

Mignini F, Tomassoni D, Traini E, Vitali M, Scuri S, Baldoni E, Grappasonni I, Cocchioni M.

Environ Toxicol. 2009 Dec;24(6):594-602. doi: 10.1002/tox.20464.

PMID:
19051261
3.

HLA-B8,DR3 haplotype affects lymphocyte blood levels.

Caruso C, Bongiardina C, Candore G, Cigna D, Romano GC, Colucci AT, Di Lorenzo G, Gervasi F, Manno M, Potestio M, Tantillo G.

Immunol Invest. 1997 Apr;26(3):333-40.

PMID:
9129986
4.

In vitro cytokine production by HLA-B8,DR3 positive subjects.

Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C.

Autoimmunity. 1994;18(2):121-32.

PMID:
7742473
5.

Soluble interleukin-2 receptor secretion defect in vitro in HLA-B8, DR3 positive subjects.

Modica MA, di Lorenzo G, Galluzzo A, Giordano C, Portelli MR, Candore G, Caruso C.

Autoimmunity. 1990;7(2-3):87-96.

PMID:
2104185
6.

Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-positive subjects.

Caruso C, Candore G, Colucci AT, Cigna D, Modica MA, Tantillo G, Salerno A.

Hum Immunol. 1993 Nov;38(3):226-30.

PMID:
8106282
7.
8.

HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2.

Candore G, Colucci AT, Modica MA, Caruso C.

Immunopharmacol Immunotoxicol. 1991;13(4):551-61.

PMID:
1774436
9.

[Occupational exposure to hexavalent chromium during aircraft painting].

Gherardi M, Gatto MP, Gordiani A, Paci E, Proietto A.

G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):553-5. Italian.

PMID:
18409827
10.

HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.

Modica MA, Cammarata G, Caruso C.

J Immunogenet. 1990 Feb-Apr;17(1-2):101-7.

PMID:
2212697
11.

In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction.

Lio D, D'Anna C, Gervasi F, Cigna D, Modica MA, Candore G, Caruso C.

Hum Immunol. 1995 Nov;44(3):170-4.

PMID:
8666553
12.

Sampling and analysis considerations for the determination of hexavalent chromium in workplace air.

Ashley K, Howe AM, Demange M, Nygren O.

J Environ Monit. 2003 Oct;5(5):707-16. Review.

PMID:
14587839
13.

Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1.

Hashimoto S, Michalski JP, Berman MA, McCombs C.

Clin Exp Immunol. 1990 Feb;79(2):227-32.

14.

T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.

Candore G, Cigna D, Todaro M, De Maria R, Stassi G, Giordano C, Caruso C.

Hum Immunol. 1995 Apr;42(4):289-94.

PMID:
7558912
15.

Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.

Stassi G, Todaro M, De Maria R, Candore G, Cigna D, Caruso C, Galluzzo A, Giordano C.

Hum Immunol. 1997 Jun;55(1):39-45.

PMID:
9328788
16.

Effects of chronic chromium(vi) exposure on blood element homeostasis: an epidemiological study.

Song Y, Zhang J, Yu S, Wang T, Cui X, Du X, Jia G.

Metallomics. 2012 May;4(5):463-72. doi: 10.1039/c2mt20051a. Epub 2012 Apr 23.

PMID:
22522219
17.

Effects of chromium on lymphocyte subsets and immunoglobulins from normal population and exposed workers.

Boscolo P, Di Gioacchino M, Bavazzano P, White M, Sabbioni E.

Life Sci. 1997;60(16):1319-25.

PMID:
9096252
18.

An assessment and quantitative uncertainty analysis of the health risks to workers exposed to chromium contaminated soils.

Paustenbach DJ, Meyer DM, Sheehan PJ, Lau V.

Toxicol Ind Health. 1991 May;7(3):159-96.

PMID:
1949057
19.

Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.

Godot V, Harraga S, Beurton I, Tiberghien P, Sarciron E, Gottstein B, Vuitton DA.

Clin Exp Immunol. 2000 Sep;121(3):491-8.

20.

Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity.

Lio D, Candore G, Romano GC, D'Anna C, Gervasi F, Di Lorenzo G, Modica MA, Potestio M, Caruso C.

Cytokines Cell Mol Ther. 1997 Dec;3(4):217-24. Review.

PMID:
9740350
Items per page

Supplemental Content

Write to the Help Desk